FBN1 and Marfan syndrome: Notably, in some genetic aortic diseases such as Marfan syndrome (characterized by FBN1 mutation) and Loeys–Dietz syndrome (characterized by TGFBR1/2 mutations), excessive activation of the TGF-β signaling pathway has been observed [9,10].